OnCoCross Co

OnCoCross Co Current Ratio

Current Ratio of OnCoCross Co (382150.KQ) as of Nov 19, 2026.

Current Ratio

-

Last updated:

Current Ratio of OnCoCross Co is 2026 - . Current Ratio of OnCoCross Co was 2025 - . It decreases by % lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

OnCoCross Co Stock analysis

What does OnCoCross Co do? OnCoCross Co Ltd develops an AI-driven platform for new drug research and development, focusing on analyzing gene expression data to match optimal disease treatments. The company targets rare diseases, cancer, and dementia through its original technology, creating solutions for intractable conditions. Its primary revenue comes from licensing the AI platform to pharmaceutical companies and research institutions seeking advanced drug discovery tools. The firm serves clients in the biotechnology sector who require innovative approaches to develop treatments for complex medical challenges. The company's platform enables precise matching of drug candidates to specific diseases by processing transcriptome data, which is critical for developing targeted therapies. Pharmaceutical firms and research organizations purchase the AI platform to accelerate their R&D processes, reducing time and costs associated with traditional drug development. This service is particularly valuable for addressing rare and complex diseases where conventional methods have limited success. OnCoCross Co Ltd's business model centers on providing a specialized AI solution that transforms how drug development is approached, especially for diseases with high unmet medical needs. By leveraging its proprietary technology, the company offers a unique value proposition to biotech and pharmaceutical companies aiming to innovate in treatment development. The focus on rare diseases and cancer positions the firm as a key player in advancing personalized medicine solutions. OnCoCross Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about OnCoCross Co stock

On Eulerpool you can find the complete historical development of Current Ratio OnCoCross Co since 2006 – with annual values, charts, and detailed analysis.

The Current Ratio measures a company's ability to pay short-term obligations. A ratio above 1 indicates that current assets exceed current liabilities.

Current Ratio = Current Assets / Current Liabilities

A 'good' varies by industry and company stage. On Eulerpool, you can compare Current Ratio's OnCoCross Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — OnCoCross Co

All Key Metrics — OnCoCross Co